Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietins in Management of Anemia of End Stage Renal Disease: A Prospective Study From Qatar.

NCT02049346 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT02049346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietins in Management of Anemia of End Stage Renal Disease: A Prospective Study From Qatar.
Lead sponsor
Hamad Medical Corporation
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2013
Enrollment
327 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia of end stage renal disease